EPHB4 and cancer: Future elucidation of the specific role of this newly described ubiquitin–ligase complex towards controlling EphB4 protein levels may provide novel molecular agents and targeting strategies towards down-modulation of the pathological effects associated with EphB4 in cancer and human disease.